| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.82B | +0.1% |
| Cost of Revenue | $557.6M | -6.0% |
| Gross Profit | $2.26B | +1.7% |
| R&D Expense | $490.1M | -9.3% |
| SG&A Expense | $268.8M | +2.1% |
| Operating Income | $658.6M | +39.4% |
| Pre-tax Income | $695.5M | +43.1% |
| Income Tax | $128.7M | +41.4% |
| Net Income | $566.8M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.07B | +34.8% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $389.0M | -14.5% |
| Inventory | $76.4M | +112.9% |
| Current Assets | $2.11B | +14.1% |
| Total Assets | $5.61B | +6.9% |
| Current Liabilities | $1.49B | +1.1% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $792.4M | +21.3% |
| Capital Expenditures | $30.4M | -43.9% |
| Investing Cash Flow | -$59.2M | -262.7% |
| Financing Cash Flow | -$457.0M | +30.0% |
| Free Cash Flow | $762.0M | +27.2% |
| +43.5% |
| EPS (Basic) | $9.65 | +46.4% |
| EPS (Diluted) | $9.55 | +45.8% |
| Stockholders' Equity |
| $3.13B |
| +11.8% |